3-Fluoro-4-methoxybenzimidamide, 98%, 250mg

{4-[6-chloro-4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}(phenyl)methanone, 95.0%, 5g

Ethyl 2-((4-methoxyphenyl)amino)-2-oxoacetate, 95+%, 1g

4-Methyl-3-(trifluoromethyl)benzyl alcohol, 95+%, 1g

(E)-3-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acrylic acid, 95.0%, 1g

2,4-Dichloronicotinaldehyde, 98.0%, 5g

2-(2-Hydroxyethoxy)benzoic acid, 95%, 1g

Ethyl(isopropyl)sulfamoyl chloride, 1g

(2E)-3-(2-chlorophenyl)-1-(3,4-dichlorophenyl)prop-2-en-1-one, 95.0%, 10g

(R)-3-Aminopyrrolidin-2-one hydrochloride, 95.0%, 250mg

5-Chloroindole-2-carboxylic acid, 95.0%, 1g

2-Methylimidazo[1,2-a]pyridine-7-carboxylic acid hydrochloride, 95%, 250mg

Colonna capillare per GC ROTI®Cap-1, 25 m, 0.20 mm, 0.10 µm, 1 Pezzo(i)